Use of β-hydroxy-β-methylbutyrate to Counteract Muscle Loss in Men With Prostate Cancer on Androgen Ablation

NCT01607879 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Standard of care ADT + (HMB + arginine + glutamine)
OTHER: Standard of care ADT

Sponsor

Medical College of Wisconsin